MUMBAI, India, Aug. 31 -- Intellectual Property India has published a patent application (202611083682 A) filed by Chhatrapati Shahu Ji Maharaj University on July 08, 2026, for Bromopyridyl Hydantoin Therapeutic Composition.
Inventors include Anurag Kumar Mishra; Poornima Pandey; Dr. Ajay Kumar; and Mr. A. Rajendiran.
The application for the patent was published on August 28, 2026, under issue no. 35/2026.
Abstract: Disclosed is a pharmaceutical composition for anticonvulsant therapy. The pharmaceutical composition comprises a therapeutically effective amount of 5-(3-bromo-2-pyridyl)-5-phenylimidazolidine-2,4-dione as an active pharmaceutical ingredient and at least one pharmaceutically acceptable carrier. The active pharmaceutical ingredient comprises an imidazolidine-2,4-dione scaffold substituted at a fifth position with a phenyl group and a 3-bromo-2-pyridyl group. The 3-bromo-2-pyridyl group is bonded through a pyridyl ring carbon bearing a bromine substituent adjacent to a pyridyl nitrogen atom. The phenyl group and the 3-bromo-2-pyridyl group form a 5,5-disubstituted hydantoin structure suitable for anticonvulsant therapy. Fig. 1 Dated July 6, 2026 / Kumar Tushar Srivastava IN/PA- 3973 Agent for the Applicant
Disclaimer: Curated by HT Syndication.
